Most pharmaceutical and medical devices companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for outsourcing. Consequently, pharmaceutical and medical device companies are inclined toward outsourcing to concentrate on R&D and marketing of their products by minimizing the time invested in manufacturing practices. The market for contract manufacturing shows tremendous potential due to growth in the medical device industry, growing regulatory concerns and increasing demand from emerging countries.
This research report provides a detailed analysis of the global healthcare contract manufacturing outsourcing (CMO) market and helps in understanding the various driving factors for the growth of the market. The market overview section of this report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of this market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global healthcare CMO market.
The report discusses the healthcare CMO market based on different pharmaceutical and medical device contract manufacturing services. Pharmaceutical contract manufacturing services comprise active pharmaceutical ingredients (API) manufacturing, final dosage formulations (FDF) manufacturing and packaging. Medical device contract manufacturing services include design outsourcing, device manufacturing and final goods assembly.
The global healthcare CMO market has been segmented based on the parameters mentioned above. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million, considering 2012 as the base year for calculation and 2011 as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.
The healthcare CMO market by geography has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of World (RoW). The study further offers recommendations and highlights of the market, which would be useful for existing and new market players to sustain and grow in the global healthcare CMO market.
The report concludes with the company profiles section, which includes key information about the major players and market share analysis (value %) of the pharmaceutical contract manufacturing market for the year 2012. Key players profiled in this report include Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc. and Greatbatch, Inc.
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote